ALX Oncology Holdings Inc. (ALXO) Tops Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts ALXO Hot Sheet
Join SI Premium – FREE
ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q1 EPS of ($0.17), $0.02 better than the analyst estimate of ($0.19).
For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
- Raymond James Downgrades Accelerant Holdings (ARX) to Market Perform
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
